Food, Global Health 3 min

Bacterial viruses: our faithful allies against antibiotic resistance

PRESS RELEASE -Viruses may sometimes be our enemies, but they can also be our allies. When our medicines are no longer effective, viruses can be valuable partners in defeating pathogenic bacteria. But more importantly, viruses do not lead to new antibiotic resistance in bacteria. Such was the conclusion of an INRAE study, published on 25 October 2021 in the journal ISME Communications.

Published on 25 October 2021

illustration Bacterial viruses: our faithful allies against antibiotic resistance
© Pixabay

It is a fact that more and more bacteria are showing antibiotic resistance. Information campaigns have raised awareness among the general public that the main cause of antibiotic resistance is the high ‘selection pressure’ on bacteria due to massive and inappropriate use of antibiotics in both humans and animals.

But this is not the only explanation. A set of mechanisms in bacteria, known as horizontal gene transfers, are also involved. Bacteria are able to exchange DNA material with each other. Some of the DNA material that is exchanged does not contribute anything specific, while some could confer antibiotic resistance. Understanding the mechanisms by which the material carrying resistance genes is transferred could help scientists identify a new way to fight resistant bacteria.

Do bacteria exchange DNA material?


This DNA material can either be released into the environment (the material is then free for all other bacteria to incorporate), or passed on via direct contact between two bacteria, a process called conjugation. A third route of gene transmission uses bacteriophages, or small viruses in bacteria, which are able to pass their DNA from one bacterium to another.

Bacteriophages: a vector of resistance?

Over the last decade, a question has divided the scientific community: are bacteriophages, especially those used in phage therapy, capable of transferring antibiotic resistance genes to bacteria? Although a 2013 scientific article* published in Nature found that bacteriophages could indeed do so, this answer has not put the matter to rest.

The controversy caught the attention of a team of INRAE researchers specialised in bacteriophages. The scientists conducted metagenomic research (analysis of the whole genome) on bacteriophages from pig fecal samples of 14 farms. Using in-depth computer analyses, the researchers finely characterised the DNA of all these bacteriophages and came to a clear conclusion: the bacteriophages studied do not possess a single antibiotic resistance gene. They cannot therefore supply resistance genes to bacteria.

This research sheds light on the issue of antibiotic resistance, a key public health concern. Bacteriophages continue to be used as allies in the fight against antibiotic-resistant bacteria through phage therapy. This practice, which is not yet widespread, uses bacteriophages on patients infected with bacteria that are resistant to all antibiotics. Bacteriophages attack and destroy the resistant bacteria, without the possibility of passing on resistance genes to other bacteria. The therapy offers hope in the fight against the growing phenomenon of antibiotic resistance.

* Modi et al. Antibiotic treatment expands the resistance reservoir and ecological network of the phage metagenome Nature. 2013, 499(7457):219-22



Billaud, M., Lamy-Besnier, Q., Lossouarn, J. et al. Analysis of viromes and microbiomes from pig fecal samples reveals that phages and prophages rarely carry antibiotic resistance genes. ISME COMMUN. 1, 55 (2021).


Learn more

Food, Global Health

Revealing promising bacteriophages hidden in the microbiota

PRESS RELEASE – What if our understanding of the interactions between bacteria and bacteriophages (bacterial viruses) in the microbiota could give rise to new weapons to fight antibiotic-resistant bacteria? INRAE scientists have cultured bacteriophages and bacteria from human faecal samples and for the first time studied their interactions. Their findings, published on 17 January 2020 in Nature Communications, revealed the emergence of two types of bacteriophage with markedly contrasting infective potential within the intestinal microbiota they studied. The most virulent may prove useful in phage therapy, an alternative to treatment with antibiotics.

17 January 2020

Food, Global Health

Fighting antimicrobial resistance in Africa: how to better take into account the needs of small African farms

Antimicrobial resistance in Africa is becoming a great cause of concern. The issue, however, is not a simple one, since although the continent has the lowest use of antimicrobials in livestock production, pathogens of animal origin have been associated with high antimicrobial resistance. An article published in Emerging Infectious Diseases identifies the culprits behind this paradox, namely, a lack of knowledge and a misuse of antimicrobials in many African farms. To address this major public health problem, a research team led by Christian Ducrot and François Roger—researchers at INRAE and CIRAD respectively—advocate for policies aimed at improving access to veterinary drugs and developing innovative social and technical interventions for the use of antimicrobials, adapted to small African farms and designed directly with the farmers.

28 September 2021

Food, Global Health

When bacteria adapt to new antimicrobials

PRESS RELEASE - The rise of antibiotic resistance jeopardizes current treatments and encourages the search for new targets for antibacterial agents. A new type of antibiotic is being developed to defeat the multi-resistant strains of Staphylococcus aureus. INRA researchers and their colleagues from the Cochin Institute (INSERM, CNRS, and University of Paris) have questioned the rationale behind the choice of this target. Their results, published in Cell Reports (17 December 2019), demonstrate how an infected host can offer bacteria ways to escape1 despite being treated with this new kind of antibiotic.

18 December 2019